For Year 2025-26, Mono Pharmacare reports the following shareholding: Total Promoters at 56.72%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 43.28%. This breakdown provides a quick snapshot of ownership distribution for Mono Pharmacare in 2025-26.